Skip to main content
Study

Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014.

Moore TJ, Furberg CD, Mattison DR, et al. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014. Pharmacoepidemiol Drug Saf. 2016;25(6):713-8. doi:10.1002/pds.3979.

Save

Print

April 6, 2016
Moore TJ, Furberg CD, Mattison DR, et al. Pharmacoepidemiol Drug Saf. 2016;25:713-8.

According to this study, many adverse drug event reports submitted by drug manufacturers to the Food and Drug Administration were incomplete. The authors advocate for the FDA to update their reporting requirements and compliance policies.

Save

Print

Cite
Citation

Moore TJ, Furberg CD, Mattison DR, et al. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014. Pharmacoepidemiol Drug Saf. 2016;25(6):713-8. doi:10.1002/pds.3979.